S. Adhikary and M. Eilers, Transcriptional regulation and transformation by Myc proteins, Nature Reviews Molecular Cell Biology, vol.17, issue.8, pp.635-680, 2005.
DOI : 10.1073/pnas.0832317100

M. Eilers and R. Eisenman, Myc's broad reach, Genes & Development, vol.22, issue.20, pp.2755-66, 2008.
DOI : 10.1101/gad.1712408

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751281

B. Hoffman, A. Amanullah, M. Shafarenko, and D. Liebermann, The protooncogene c-myc in hematopoietic development and leukemogenesis

A. Renneville, C. Roumier, and V. Biggio, Cooperating gene mutations in acute myeloid leukemia: a review of the literature, Leukemia, vol.106, issue.5, pp.915-946, 2008.
DOI : 10.1038/leu.2008.19

D. Gilliland and J. Griffin, The roles of FLT3 in hematopoiesis and leukemia, Blood, vol.100, issue.5, pp.1532-1574, 2002.
DOI : 10.1182/blood-2002-02-0492

C. Muellar-tidow, B. Steffen, and T. Cauvet, Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells, Molecular and Cellular Biology, vol.24, issue.7, pp.2890-904, 2004.
DOI : 10.1128/MCB.24.7.2890-2904.2004

L. Johansen, A. Iwama, and T. Lodie, c-Myc Is a Critical Target for C/EBP?? in Granulopoiesis, Molecular and Cellular Biology, vol.21, issue.11, pp.3789-806, 2001.
DOI : 10.1128/MCB.21.11.3789-3806.2001

M. Slovak, J. Ho, and M. Pettenati, Localization of amplified MYC gene sequences to double minute chromosomes in acute myelogenous leukemia, Genes, Chromosomes and Cancer, vol.9, issue.1, pp.62-69, 1994.
DOI : 10.1002/gcc.2870090111

H. Luo, O. Neal, J. Kreisel, F. , L. Beau et al., c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations, Blood, vol.106, issue.7, pp.2542-61, 2005.
DOI : 10.1182/blood-2005-02-0734

J. Chen, O. Odenike, and J. Rowley, Leukaemogenesis: more than mutant genes, Nature Reviews Cancer, vol.5, issue.1, pp.23-29, 2010.
DOI : 10.1038/nrc2765

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972637

R. Cao and Y. Zhang, The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3, Current Opinion in Genetics & Development, vol.14, issue.2, pp.155-64, 2004.
DOI : 10.1016/j.gde.2004.02.001

R. Villa, D. Pasini, and A. Gutierrez, Role of the Polycomb Repressive Complex 2 in Acute Promyelocytic Leukemia, Cancer Cell, vol.11, issue.6, pp.513-538, 2007.
DOI : 10.1016/j.ccr.2007.04.009

W. Fiskus, Y. Wang, and A. Sreekumar, Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells, Blood, vol.114, issue.13, pp.2733-2776, 2009.
DOI : 10.1182/blood-2009-03-213496

A. Fatica and I. Bozzoni, Role of microRNAs in hematological malignancies, Expert Review of Hematology, vol.2, issue.4, pp.415-438, 2009.
DOI : 10.1586/ehm.09.32

S. Sander, L. Bullinger, and K. Klapproth, MYC stimulates EZH2 expression by repression of its negative regulator miR-26a, Blood, vol.112, issue.10, pp.4202-4214, 2008.
DOI : 10.1182/blood-2008-03-147645

T. Chang, D. Yu, and Y. Lee, Widespread microRNA repression by Myc contributes to tumorigenesis, Nature Genetics, vol.121, issue.1, pp.43-50, 2008.
DOI : 10.1038/ng.2007.30

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628762

S. Varambally, Q. Cao, and R. Mani, Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer, Science, vol.322, issue.5908, pp.1695-1704, 2008.
DOI : 10.1126/science.1165395

J. Friedman, G. Liang, and C. Liu, The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2, Cancer Research, vol.69, issue.6, pp.2623-2632, 2009.
DOI : 10.1158/0008-5472.CAN-08-3114

A. Juan, R. Kumar, J. Marx, R. Young, and V. Sartorelli, Mir-214-Dependent Regulation of the Polycomb Protein Ezh2 in Skeletal Muscle and Embryonic Stem Cells, Molecular Cell, vol.36, issue.1, pp.61-74, 2009.
DOI : 10.1016/j.molcel.2009.08.008

K. Szulwach, X. Li, and R. Smrt, Cross talk between microRNA and epigenetic regulation in adult neurogenesis, The Journal of Cell Biology, vol.127, issue.1, pp.127-168, 2010.
DOI : 10.1083/jcb.200908151.dv

G. Jiang, A. Albihn, T. Tang, Z. Tian, and M. Henriksson, Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid, Leukemia Research, vol.32, issue.2, pp.297-307, 2008.
DOI : 10.1016/j.leukres.2007.06.021

B. Xu, P. Liu, J. Li, and H. Lu, All-trans retinoic acid induces Thrombospondin-1 expression in acute promyelocytic leukemia cells though down-regulation of its transcription repressor, c-MYC oncoprotein, Biochemical and Biophysical Research Communications, vol.382, issue.4, pp.790-794, 2009.
DOI : 10.1016/j.bbrc.2009.03.105

S. Eckhardt, A. Dai, K. Davidson, B. Forseth, G. Wahl et al., Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc., Proceedings of the National Academy of Sciences, vol.91, issue.14, pp.6674-6682, 1994.
DOI : 10.1073/pnas.91.14.6674

M. Huang, Y. Cheng, C. Liu, S. Lin, and H. Liu, A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia, Experimental Hematology, vol.34, issue.11, pp.1480-1489, 2006.
DOI : 10.1016/j.exphem.2006.06.019

A. Bracken, D. Pasini, M. Capra, E. Prosperini, E. Colli et al., EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer, The EMBO Journal, vol.22, issue.20, pp.5323-5358, 2003.
DOI : 10.1093/emboj/cdg542

J. Kota, R. Chivukula, O. Donnell, and K. , Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model, Cell, vol.137, issue.6, pp.1005-1022, 2009.
DOI : 10.1016/j.cell.2009.04.021

J. Lu, M. He, and L. Wang, MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2, Cancer Research, vol.71, issue.1, pp.225-258, 2011.
DOI : 10.1158/0008-5472.CAN-10-1850

J. Huse, C. Brennan, and D. Hambardzumyan, The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo, Genes & Development, vol.23, issue.11, pp.1327-1364, 2009.
DOI : 10.1101/gad.1777409

J. Gabert, E. Beillard, and V. Van-der-velden, Standardization and quality control studies of ???real-time??? quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia ??? A Europe Against Cancer Program, Leukemia, vol.17, issue.12, pp.2318-57, 2003.
DOI : 10.1038/sj.leu.2403135

G. Cimino, F. Lo-coco, and S. Fenu, Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia, Cancer Research, vol.66, issue.17, pp.8903-8914, 2006.
DOI : 10.1158/0008-5472.CAN-05-2726

D. Marchis, M. Ballarino, M. Salvatori, B. Puzzolo, M. Bozzoni et al., A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells, Leukemia, vol.18, issue.5, pp.856-62, 2009.
DOI : 10.1038/leu.2008.372